The Food and Drug Administration (FDA) on Friday extended its authorization for the booster dose of the coronavirus vaccine to all adults (until now it was only recommended to the elderly and those who were at special risk for health problems or because of their work), given the rise in hospitalizations in people who have already received the initial doses, and the risk posed by the holiday season at the end of the year.
This measure simplifies what has so far been a confusing list of who is eligible, by allowing anyone 18 years of age or older to choose the Pfizer or Moderna pharmaceutical booster six months after their last dose, regardless of which vaccine they receive. received first.
Expanding information ...
